Search

everythinglearnresearchcommunity

for

Search:↓

Weekly Azathioprine Pulse therapy is more effective than Betamethasone Oral Mini-Pulse for hair regrowth in moderate to severe Alopecia Areata.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Bempikibart may help regrow hair in people with alopecia areata.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Baricitinib is effective and safe for treating severe alopecia areata.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Compound glycyrrhizin combined with conventional treatments effectively and safely promotes hair regrowth in alopecia areata patients.

Compound glycyrrhizin with conventional treatments is effective and safe for promoting hair regrowth in alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Certain NK cell changes in blood may indicate alopecia areata progression.

Baricitinib is effective for severe alopecia areata but has some side effects.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Changes in skin bacteria may relate to alopecia areata severity.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Rezpegaldesleukin shows promise for treating severe alopecia areata.